ARTA
ALXN
A.R.T. Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,519
| Closed | -$394K | – | 113 |
|
|
2020
Q4 | $394K | Sell |
2,519
-3,900
| -61% | -$610K | 1.82% | 18 |
|
|
2020
Q3 | $735K | Buy |
+6,419
| New | +$735K | 4.15% | 4 |
|
|
2020
Q1 | – | Sell |
-14,119
| Closed | -$1.53M | – | 1212 |
|
|
2019
Q4 | $1.53M | Sell |
14,119
-41,281
| -75% | -$4.46M | 0.08% | 398 |
|
|
2019
Q3 | $5.43M | Buy |
+55,400
| New | +$5.43M | 0.27% | 64 |
|
|
2019
Q1 | – | Sell |
-23,800
| Closed | -$2.32M | – | 1745 |
|
|
2018
Q4 | $2.32M | Buy |
23,800
+4,700
| +25% | +$458K | 0.15% | 197 |
|
|
2018
Q3 | $2.66M | Buy |
+19,100
| New | +$2.66M | 0.12% | 229 |
|
|
2018
Q2 | – | Sell |
-59,800
| Closed | -$6.67M | – | 1896 |
|
|
2018
Q1 | $6.67M | Sell |
59,800
-16,000
| -21% | -$1.78M | 0.27% | 53 |
|
|
2017
Q4 | $9.06M | Sell |
75,800
-18,300
| -19% | -$2.19M | 0.4% | 22 |
|
|
2017
Q3 | $13.2M | Buy |
94,100
+39,200
| +71% | +$5.5M | 0.67% | 6 |
|
|
2017
Q2 | $6.68M | Sell |
54,900
-31,000
| -36% | -$3.77M | 0.35% | 43 |
|
|
2017
Q1 | $10.4M | Buy |
+85,900
| New | +$10.4M | 0.48% | 24 |
|
|
2016
Q4 | – | Sell |
-10,500
| Closed | -$1.29M | – | 1445 |
|
|
2016
Q3 | $1.29M | Buy |
10,500
+104
| +1% | +$12.7K | 0.42% | 46 |
|
|
2016
Q2 | $1.21M | Buy |
+10,396
| New | +$1.21M | 0.06% | 474 |
|
|
2015
Q2 | – | Sell |
-114,474
| Closed | -$19.8M | – | 1798 |
|
|
2015
Q1 | $19.8M | Buy |
114,474
+44,552
| +64% | +$7.72M | 0.68% | 14 |
|
|
2014
Q4 | $12.9M | Buy |
+69,922
| New | +$12.9M | 0.48% | 22 |
|
|
2014
Q3 | – | Sell |
-28,457
| Closed | -$4.45M | – | 1603 |
|
|
2014
Q2 | $4.45M | Sell |
28,457
-13,687
| -32% | -$2.14M | 0.23% | 100 |
|
|
2014
Q1 | $6.41M | Buy |
+42,144
| New | +$6.41M | 0.34% | 54 |
|
|
2013
Q4 | – | Sell |
-41,719
| Closed | -$4.85M | – | 1608 |
|
|
2013
Q3 | $4.85M | Sell |
41,719
-71,169
| -63% | -$8.27M | 0.26% | 82 |
|
|
2013
Q2 | $10.4M | Buy |
+112,888
| New | +$10.4M | 0.34% | 49 |
|